Diabetes and COVID-19, a link revealed

References

[1] HuB, GuoH, ZhouP, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2022;19:141–54.

[2] WilliamsonEJ, WalkerAJ, BhaskaranK, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430–6.

[3] LuoL, HanW, DuJ, et al. Chenodeoxycholic acid from bile inhibits influenza a virus replication via blocking nuclear export of viral ribonucleoprotein complexes. Molecules 2018;23:3315.

[4] WuD, ShuT, YangX, et al. Serum metabolomic and lipidomic alterations associated with COVID-19. Natl Sci Rev 2020;7:1157–68.

[5] AkanumaY, MoritaM, FukuzawaN, et al. Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients. Diabetologia 1988;31:831–5.

[6] ChaleckisR, Murakami I, TakadaJ, et al. Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci USA 2016;113:4252–9.

[7] TongL, XiaoX, LiM, et al. A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2. Nat Metab 2022;4:547–58.

[8] CodoAC, Davanzo GG, MonteiroLB, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab 2020;32:446.

[9] MengX, Tancharoen S, KawaharaKI, et al. 1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions. Int J Immunopathol Pharmacol 2010;23:105–19.

[10] KawasakiT, Yamanouchi T, KashiwabaraA, et al. The influence of traditional Chinese herbal drugs on serum 1,5-anhydroglucitol levels. Diabetes Res Clin Pract 2000;50:97–101.

RIGHTS & PERMISSIONS

The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.